Search research articles
Contact Us
Filters
Showing results (171-180 of 193) with videos related to
Page
of 20
Sort By:
Arthritis Care & Research
|
September 28, 2020
Characteristics of Patients With Antiphospholipid Antibody Positivity in the APS ACTION International Clinical Database and Repository
Ecem Sevim, Diane Zisa, Danieli Andrade, et al.
The Lancet. Rheumatology
|
February 1, 2024
Mycophenolate mofetil withdrawal in patients with systemic lupus erythematosus: a multicentre, open-label, randomised controlled trial
Eliza F Chakravarty, Tammy Utset, Diane L Kamen, et al.
Lupus
|
July 25, 2020
Cluster analysis for the identification of clinical phenotypes among antiphospholipid antibody-positive patients from the APS ACTION Registry
Stéphane Zuily, Isabelle Clerc-Urmès, Cédric Bauman, et al.
Advances in Rheumatology (London, England)
|
October 29, 2021
Clinical and laboratory characteristics of Brazilian versus non-Brazilian primary antiphospholipid syndrome patients in AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) clinical database and repository
Erivelton de Azevedo Lopes, Gustavo Guimarães Moreira Balbi, Maria G Tektonidou, et al.
Rheumatology (Oxford, England)
|
October 18, 2024
ANA-positive versus ANA-negative Antiphospholipid Antibody-positive Patients: Results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Clinical Database and Repository ("Registry")
Irene Cecchi, Massimo Radin, Silvia Grazietta Foddai, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
March 2, 2023
Anti-Neutrophil Extracellular Trap Antibodies in Antiphospholipid Antibody-Positive Patients: Results From the Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Clinical Database and Repository
Yu Zuo, Sherwin Navaz, Alex Tsodikov, et al.
Rheumatology (Oxford, England)
|
June 12, 2023
Damage measured by Damage Index for Antiphospholipid Syndrome (DIAPS) in antiphospholipid antibody-positive patients included in the APS ACTION registry
Gustavo G M Balbi, Yasaman Ahmadzadeh, Maria G Tektonidou, et al.
Lupus
|
October 7, 2022
Immunosuppression use in primary antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ("Registry")
Zeynep B Erton, Rebecca K Leaf, Danieli de Andrade, et al.
Seminars in Arthritis and Rheumatism
|
June 3, 2019
The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort
Massimo Radin, Savino Sciascia, Doruk Erkan, et al.
Arthritis Care & Research
|
July 7, 2025
Development of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-C Report: Assessment of Patient Scenarios (Derivation Cohort) and Refinement of Definitions
Medha Barbhaiya, Stephane Zuily, Deanna Jannat-Khah, et al.
Page
of 20
Search research articles
Search
Showing results (171-180 of 193) with videos related to
Sort By:
Page
of 20
Arthritis Care & Research
|
September 28, 2020
Characteristics of Patients With Antiphospholipid Antibody Positivity in the APS ACTION International Clinical Database and Repository
Ecem Sevim, Diane Zisa, Danieli Andrade, et al.
The Lancet. Rheumatology
|
February 1, 2024
Mycophenolate mofetil withdrawal in patients with systemic lupus erythematosus: a multicentre, open-label, randomised controlled trial
Eliza F Chakravarty, Tammy Utset, Diane L Kamen, et al.
Lupus
|
July 25, 2020
Cluster analysis for the identification of clinical phenotypes among antiphospholipid antibody-positive patients from the APS ACTION Registry
Stéphane Zuily, Isabelle Clerc-Urmès, Cédric Bauman, et al.
Advances in Rheumatology (London, England)
|
October 29, 2021
Clinical and laboratory characteristics of Brazilian versus non-Brazilian primary antiphospholipid syndrome patients in AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) clinical database and repository
Erivelton de Azevedo Lopes, Gustavo Guimarães Moreira Balbi, Maria G Tektonidou, et al.
Rheumatology (Oxford, England)
|
October 18, 2024
ANA-positive versus ANA-negative Antiphospholipid Antibody-positive Patients: Results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Clinical Database and Repository ("Registry")
Irene Cecchi, Massimo Radin, Silvia Grazietta Foddai, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
March 2, 2023
Anti-Neutrophil Extracellular Trap Antibodies in Antiphospholipid Antibody-Positive Patients: Results From the Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Clinical Database and Repository
Yu Zuo, Sherwin Navaz, Alex Tsodikov, et al.
Rheumatology (Oxford, England)
|
June 12, 2023
Damage measured by Damage Index for Antiphospholipid Syndrome (DIAPS) in antiphospholipid antibody-positive patients included in the APS ACTION registry
Gustavo G M Balbi, Yasaman Ahmadzadeh, Maria G Tektonidou, et al.
Lupus
|
October 7, 2022
Immunosuppression use in primary antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ("Registry")
Zeynep B Erton, Rebecca K Leaf, Danieli de Andrade, et al.
Seminars in Arthritis and Rheumatism
|
June 3, 2019
The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort
Massimo Radin, Savino Sciascia, Doruk Erkan, et al.
Arthritis Care & Research
|
July 7, 2025
Development of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-C Report: Assessment of Patient Scenarios (Derivation Cohort) and Refinement of Definitions
Medha Barbhaiya, Stephane Zuily, Deanna Jannat-Khah, et al.
Page
of 20